280 related articles for article (PubMed ID: 23371292)
41. Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.
Mwenifumbo JC; Lessov-Schlaggar CN; Zhou Q; Krasnow RE; Swan GE; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2008 Jan; 83(1):115-21. PubMed ID: 17522595
[TBL] [Abstract][Full Text] [Related]
42. Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers.
Chenoweth MJ; Sylvestre MP; Contreras G; Novalen M; O'Loughlin J; Tyndale RF
Drug Alcohol Depend; 2016 Jan; 158():139-46. PubMed ID: 26644138
[TBL] [Abstract][Full Text] [Related]
43.
Sipe CJ; Koopmeiners JS; Donny EC; Hatsukami DK; Murphy SE
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1673-1678. PubMed ID: 32532831
[TBL] [Abstract][Full Text] [Related]
44. Influence of CYP2A6*4 genotypes on maternal serum cotinine among Chinese nonsmoking pregnant women.
Xie C; Wen X; Ding P; Liu T; He Y; Niu Z; Lin J; Yuan S; Guo X; Jia D; Chen W
Nicotine Tob Res; 2014 Apr; 16(4):406-12. PubMed ID: 24163286
[TBL] [Abstract][Full Text] [Related]
45. Factors influencing cotinine half-life during smoking abstinence in African American and Caucasian women.
Ahijevych KL; Tyndale RF; Dhatt RK; Weed HG; Browning KK
Nicotine Tob Res; 2002 Nov; 4(4):423-31. PubMed ID: 12521401
[TBL] [Abstract][Full Text] [Related]
46. Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.
Williams JM; Gandhi KK; Benowitz NL
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2582-9. PubMed ID: 20719908
[TBL] [Abstract][Full Text] [Related]
47. Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population.
Nagano T; Shimizu M; Kiyotani K; Kamataki T; Takano R; Murayama N; Shono F; Yamazaki H
Int J Environ Res Public Health; 2010 Jul; 7(7):2953-64. PubMed ID: 20717551
[TBL] [Abstract][Full Text] [Related]
48. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
[TBL] [Abstract][Full Text] [Related]
49. Urinary biomarkers for secondhand smoke.
Ino T; Ohtani T; Yoshimi I
J Clin Lab Anal; 2011; 25(5):354-8. PubMed ID: 21919071
[TBL] [Abstract][Full Text] [Related]
50. Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.
Baurley JW; Edlund CK; Pardamean CI; Conti DV; Krasnow R; Javitz HS; Hops H; Swan GE; Benowitz NL; Bergen AW
Nicotine Tob Res; 2016 Sep; 18(9):1837-1844. PubMed ID: 27113016
[TBL] [Abstract][Full Text] [Related]
51. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
[TBL] [Abstract][Full Text] [Related]
52. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
[TBL] [Abstract][Full Text] [Related]
53. Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6.
Bloom AJ; Harari O; Martinez M; Madden PA; Martin NG; Montgomery GW; Rice JP; Murphy SE; Bierut LJ; Goate A
Hum Mol Genet; 2012 Jul; 21(13):3050-62. PubMed ID: 22451501
[TBL] [Abstract][Full Text] [Related]
54. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations.
Wassenaar CA; Ye Y; Cai Q; Aldrich MC; Knight J; Spitz MR; Wu X; Blot WJ; Tyndale RF
Carcinogenesis; 2015 Jan; 36(1):99-103. PubMed ID: 25416559
[TBL] [Abstract][Full Text] [Related]
55. Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent.
Mwenifumbo JC; Al Koudsi N; Ho MK; Zhou Q; Hoffmann EB; Sellers EM; Tyndale RF
Hum Mutat; 2008 May; 29(5):679-88. PubMed ID: 18360915
[TBL] [Abstract][Full Text] [Related]
56. Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urine.
Swan GE; Lessov-Schlaggar CN; Bergen AW; He Y; Tyndale RF; Benowitz NL
Pharmacogenet Genomics; 2009 May; 19(5):388-98. PubMed ID: 19300303
[TBL] [Abstract][Full Text] [Related]
57. Nicotine metabolism and CYP2A6 allele frequencies in Koreans.
Kwon JT; Nakajima M; Chai S; Yom YK; Kim HK; Yamazaki H; Sohn DR; Yamamoto T; Kuroiwa Y; Yokoi T
Pharmacogenetics; 2001 Jun; 11(4):317-23. PubMed ID: 11434509
[TBL] [Abstract][Full Text] [Related]
58. CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents.
Huang S; Cook DG; Hinks LJ; Chen XH; Ye S; Gilg JA; Jarvis MJ; Whincup PH; Day IN
Pharmacogenet Genomics; 2005 Dec; 15(12):839-50. PubMed ID: 16272956
[TBL] [Abstract][Full Text] [Related]
59. Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways.
Liu T; Chen WQ; David SP; Tyndale RF; Wang H; Chen YM; Yu XQ; Chen W; Zhou Q; Ling WH
Eur J Endocrinol; 2011 Dec; 165(6):961-7. PubMed ID: 21964962
[TBL] [Abstract][Full Text] [Related]
60. Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior.
Tyndale RF; Sellers EM
Ther Drug Monit; 2002 Feb; 24(1):163-71. PubMed ID: 11805739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
